USANA Health Sciences (NYSE:USNA) Trading Up 4.3% Following Strong Earnings

USANA Health Sciences, Inc. (NYSE:USNA) was up 4.3% during trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $36.10 and last traded at $35.97. Approximately 16,007 shares changed hands during mid-day trading, a decline of 80% from the average daily volume of 79,591 shares. The stock had previously closed at $34.48.

The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analysts’ expectations of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.80%. During the same period in the previous year, the company earned $0.59 EPS.

Analysts Set New Price Targets

USNA has been the subject of several research reports. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th. DA Davidson dropped their price objective on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating for the company in a research note on Wednesday.

Insider Activity at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 674 shares of the firm’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Paul A. Jones sold 6,266 shares of the firm’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gilbert A. Fuller sold 674 shares of the firm’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The disclosure for this sale can be found here. Insiders sold a total of 7,940 shares of company stock valued at $311,670 in the last quarter. Insiders own 0.33% of the company’s stock.

Hedge Funds Weigh In On USANA Health Sciences

Several large investors have recently modified their holdings of USNA. BOKF NA raised its stake in shares of USANA Health Sciences by 274.5% during the first quarter. BOKF NA now owns 2,771 shares of the company’s stock valued at $133,000 after acquiring an additional 2,031 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of USANA Health Sciences by 9.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock worth $284,000 after buying an additional 494 shares during the period. Exchange Traded Concepts LLC increased its position in shares of USANA Health Sciences by 4.4% during the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock worth $292,000 after buying an additional 322 shares during the period. SG Americas Securities LLC acquired a new stake in shares of USANA Health Sciences during the second quarter worth $340,000. Finally, DGS Capital Management LLC increased its position in shares of USANA Health Sciences by 61.8% during the first quarter. DGS Capital Management LLC now owns 7,258 shares of the company’s stock worth $352,000 after buying an additional 2,773 shares during the period. Institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Price Performance

The company’s 50-day moving average price is $37.96 and its two-hundred day moving average price is $42.51. The company has a market capitalization of $720.28 million, a price-to-earnings ratio of 13.36, a PEG ratio of 1.15 and a beta of 0.89.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.